HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
复制标题
DOI:
10.1038/onc.2010.632
复制
发表时间:
2011-06-09
期刊:
影响因子:
8
通讯作者:
Liu, W.
中科院分区:
文献类型:
--
作者:
Li, Y.;Bavarva, J. H.;Wang, Z.;Guo, J.;Qian, C.;Thibodeau, S. N.;Golemis, E. A.;Liu, W.
Misregulation of the canonical Wnt/β-catenin pathway and aberrant activation of Wnt signaling target genes are common in colorectal cancer and contribute to cancer progression. Altered expression of HEF1 (Human Enhancer of Filamentation 1, also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and colorectal cancer. However, the regulation of HEF1 and the role of HEF1 in colorectal cancer tumorigenesis are not fully understood. We here identify HEF1 as a novel Wnt signaling target. The expression of HEF1 was up-regulated by Wnt3a, β-catenin, and Dvl2 in a dose-dependent fashion, and was suppressed following β-catenin down-regulation by shRNA. In addition, elevated HEF1 mRNA and protein levels were observed in colorectal cancer cell lines and primary tumor tissues, as well as in the colon and adenoma polyps of Apcmin/+ mice. Moreover, HEF1 levels in human colorectal tumor tissues increased with the tumor grade. Chromatin immunoprecipitation (ChIP) assays and HEF1 promoter analyses revealed three functional TCF-binding sites in the promoter of HEF1 responsible for HEF1 induction by Wnt signaling. Ectopic expression of HEF1 increased cell proliferation and colony formation, while down-regulation of HEF1 in SW480 cells by shRNA had the opposite effects and inhibited the xenograft tumor growth. Furthermore, overexpression of HEF1 in SW480 cells promoted cell migration and invasion. Together, our results determined a novel role of HEF1 as a mediator of the canonical Wnt/β-catenin signaling pathway for cell proliferation, migration, and tumorigenesis, as well as an important player in colorectal tumorigenesis and progression. HEF1 may represent an attractive candidate for drug targeting in colorectal cancer.
登录
查看更多内容
影响因子:
8
作者:
Donninger, H;Bonome, T;Birrer, MJ
通讯作者:
Birrer, MJ
影响因子:
6
作者:
Li, YC;Park, MJ;Kim, YN
通讯作者:
Kim, YN
影响因子:
4.8
作者:
Fujino, H;West, KA;Regan, JW
通讯作者:
Regan, JW
影响因子:
5.3
作者:
Law, SF;O'Neill, GM;Golemis, EA
通讯作者:
Golemis, EA
影响因子:
64.8
作者:
Ji, Hongbin;Ramsey, Matthew R.;Wong, Kwok-Kin
通讯作者:
Wong, Kwok-Kin